The role of long non-coding RNAs in multiple myeloma

Eur J Haematol. 2019 Jul;103(1):3-9. doi: 10.1111/ejh.13237. Epub 2019 May 29.

Abstract

Multiple myeloma (MM) is still an incurable disease, and its pathogenesis involves cytogenetics and epigenetics. In recent years, the roles of long non-coding RNAs (lncRNAs) in MM have been deeply studied by scholars. LncRNAs are defined as a class of non-protein-coding transcripts greater than 200 nucleotides in length, which are involved in a large spectrum of biological processes, including proliferation, differentiation, apoptosis, invasion, and chromatin remodeling. However, little is known about the specific mechanisms of these lncRNAs. They can act as oncogenic and/or tumor-suppressive factors in the development and progression of MM. But that how do they work remains unclear. In this review, the recent progress in the study of functional lncRNAs associated with MM was summarized and the present knowledge about their expression and roles was discussed, to provide guidance for the in-depth functional study of lncRNAs.

Keywords: lncRNAs; mechanisms; multiple myeloma.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor
  • Carcinogenesis / genetics
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / metabolism
  • Multiple Myeloma / pathology
  • RNA, Long Noncoding / genetics*

Substances

  • Biomarkers, Tumor
  • RNA, Long Noncoding